Malignant hypertension and interferon-beta: A case report

Journal of Human Hypertension

Volumn 28, Issue 5, 2014, Pages 340-341

  Rubin, S ^a   Lacraz, A ^a   Galantine, V ^a   Gosse, P ^b  

^a Renal Unit Hôpital de la Côte Basque   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; BETA INTERFERON; BISOPROLOL; IRBESARTAN; NICARDIPINE; RAMIPRIL; ANTIHYPERTENSIVE AGENT; BIPHENYL DERIVATIVE; IMMUNOLOGIC FACTOR; TETRAZOLE DERIVATIVE;

ADULT; BRAIN DISEASE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HEMOLYSIS; HUMAN; HYPERALDOSTERONISM; HYPERTENSION RETINOPATHY; KIDNEY DYSFUNCTION; LETTER; MALIGNANT HYPERTENSION; MULTIPLE SCLEROSIS; CHEMICALLY INDUCED; DRUG EFFECTS; HYPERTENSION, MALIGNANT; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BIPHENYL COMPOUNDS; BISOPROLOL; FEMALE; HUMANS; HYPERTENSION, MALIGNANT; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MULTIPLE SCLEROSIS; RAMIPRIL; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES;

EID: 84898544834     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.91     Document Type: Letter

References (9)

1. Pimenta E, Calhoun DA. Hypertensive crisis: forget the numbers. J Hypertens 2012; 30(5): 882-883.
2. van den Born B-JH, Koopmans RP, van Montfrans GA. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. Am J Hypertens 2007; 20(8): 900-906.
3. Gosse P, Coulon P, Papaioannou G, Litalien J, Lemetayer P. Impact of malignant arterial hypertension on the heart. J Hypertens 2011; 29(4): 798-802.
4. González R, Morales E, Segura J, Ruilope LM, Praga M. Long-term renal survival in malignant hypertension. Nephrol Dial Transplant 2010; 25(10): 3266-3272.
5. Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS et al. Betaadrenergic receptor blockade as a therapeutic approach for suppressing the reninangiotensin-aldosterone system in normotensive and hypertensive subjects. Am J Hypertens 1999; 12(5): 451-459.
6. Turner ST, Schwartz GL, Chapman AB, Beitelshees AL, Gums JG, Cooper-DeHoff RM et al. Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension. Am J Hypertens 2010; 23(9): 1014-1022.
7. Li Cavoli G, Bono L, Tortorici C, Giammarresi C, Rotolo U. Renal thrombotic microangiopathy induced by b-interferon. NDT Plus 2011; 4(1): 79-80.
8. Olea T, Diaz-Mancebo R, Picazo ML, Martinez Ara J, Robles A, Selgas R. Thrombotic microangiopathy associated with use of interferon-beta. Int J Nephrol Renovasc Dis 2012; 5: 97-100.
9. Orvain C, Augusto JF, Besson V, Marc G, Coppo P, Subra JF et al. Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis. Int Urol Nephrol (e-pub ahead of print 24 February 2013).